Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (NASDAQ: QNTM) is trading at $3.82, about ₹367 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 3.54% today. Indian residents can buy Quantum BioPharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$3.71
Today's high
$3.96
52 week low
$2.07
52 week high
$19.30
QNTM opened at $3.95, closed previously at $3.96, and has traded between $2.07 and $19.30 over the past 52 weeks.
About
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development. Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings. A flagship asset is Lucid-MS, a novel, proprietary chemical entity currently in Phase 2 clinical trials. Preclinical data indicates its potential to prevent and reverse the degradation of myelin, a key process underlying multiple sclerosis. Furthermore, Quantum BioPharma is developing a therapeutic solution for alcohol addiction, intended for application in hospital and clinical environments. The company's strategic investments portfolio includes various loans collateralized by residential real estate. Previously known as FSD Pharma Inc., the company adopted its current name, Quantum BioPharma Ltd., in August 2024.
Key statistics
Avg. volume
252.47K
Market cap
$24.44M
P/E Ratio
-0.68
Price-to-sales ratio
0.00
Enterprise value
$23.96M
Free cash flow yield
-34.94%
Debt-to-equity ratio
0.12
Return on equity
-378.70%
ROIC
-219.67%
Beta
0.45
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$0.00
Earnings per share
-$8.11
Free cash flow
-$8.38M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$25.79M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy Quantum BioPharma from India
Indian residents can buy Quantum BioPharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Quantum BioPharma and place an order
Find Quantum BioPharma by name or by its ticker, QNTM, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Quantum BioPharma trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Quantum BioPharma position in USD and INR. Quantum BioPharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Quantum BioPharma from India
Trading and taxes when buying Quantum BioPharma from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneQuantum BioPharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Quantum BioPharma stock?
Yes. Quantum BioPharma (QNTM) has been listed on NASDAQ since 2018, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Quantum BioPharma share cost in rupees?
One Quantum BioPharma share is $3.82 — about ₹367 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Quantum BioPharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Quantum BioPharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Quantum BioPharma?
Yes. One Quantum BioPharma share is $3.82, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Quantum BioPharma.
How are gains on Quantum BioPharma shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Quantum BioPharma price. Paasa issues a capital-gains statement for your return.
Does Quantum BioPharma pay a dividend?
No. Quantum BioPharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Quantum BioPharma from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Quantum BioPharma a United States company, and does that change how it is taxed?
Quantum BioPharma trades on NASDAQ in US dollars, but the company is domiciled in Canada. Quantum BioPharma trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Quantum BioPharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Quantum BioPharma holding, its cost and its closing value.
How do I sell Quantum BioPharma and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.